Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3017477rdf:typepubmed:Citationlld:pubmed
pubmed-article:3017477lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3017477lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:3017477lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:3017477lifeskim:mentionsumls-concept:C0040018lld:lifeskim
pubmed-article:3017477lifeskim:mentionsumls-concept:C1415189lld:lifeskim
pubmed-article:3017477lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:3017477pubmed:issue3lld:pubmed
pubmed-article:3017477pubmed:dateCreated1986-10-15lld:pubmed
pubmed-article:3017477pubmed:abstractTextThrombin activation of platelets involves two receptors: glycoprotein Ib (GPIb), which affects the kinetics of the response; and, as a strong candidate for the second, essential receptor, GPV, a hydrophobic, 82-kd glycoprotein with an isoelectric point (pI) of pH 5.85 to 6.55. Whole platelets were treated with endogenous platelets calcium-activated proteases, yielding a major fragment, GPV8, with molecular weight (mol wt) of 79 kilodaltons (kd). The fragment was purified by affinity chromatography on wheat germ agglutinin followed by ion exchange chromatography on DEAE-Sephacel using first a 0 to 0.7-mol/L and then a 0 to 0.3-mol/L NaCl gradient. A rabbit was immunized with the purified GPV8 for preparation of polyclonal antibodies. Crossed immunoelectrophoresis and two-dimensional polyacrylamide gel electrophoresis (PAGE) electrophoretic blotting with the separate phases of a Triton X-114 phase partition of human platelets showed the characteristic pattern of GPV in the hydrophobic phase. During thrombin-induced platelet aggregation GPV is hydrolysed, releasing a fragment, GPVf1, to the supernatant. The fragment GPVf1 still contains a thrombin-binding site. Anti-GPV antibodies blocked GPV proteolysis, but did not inhibit platelet activation induced by thrombin. We conclude that proteolysis of GPV by thrombin is not essential for platelet activation.lld:pubmed
pubmed-article:3017477pubmed:languageenglld:pubmed
pubmed-article:3017477pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3017477pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3017477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3017477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3017477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3017477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3017477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3017477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3017477pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3017477pubmed:statusMEDLINElld:pubmed
pubmed-article:3017477pubmed:monthSeplld:pubmed
pubmed-article:3017477pubmed:issn0006-4971lld:pubmed
pubmed-article:3017477pubmed:authorpubmed-author:ClemetsonK...lld:pubmed
pubmed-article:3017477pubmed:authorpubmed-author:SchnipperingW...lld:pubmed
pubmed-article:3017477pubmed:authorpubmed-author:BienzDDlld:pubmed
pubmed-article:3017477pubmed:issnTypePrintlld:pubmed
pubmed-article:3017477pubmed:volume68lld:pubmed
pubmed-article:3017477pubmed:ownerNLMlld:pubmed
pubmed-article:3017477pubmed:authorsCompleteYlld:pubmed
pubmed-article:3017477pubmed:pagination720-5lld:pubmed
pubmed-article:3017477pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:meshHeadingpubmed-meshheading:3017477-...lld:pubmed
pubmed-article:3017477pubmed:year1986lld:pubmed
pubmed-article:3017477pubmed:articleTitleGlycoprotein V is not the thrombin activation receptor on human blood platelets.lld:pubmed
pubmed-article:3017477pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3017477pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3017477lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3017477lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3017477lld:pubmed